Does Linezolid Cause Lactic Acidosis by Inhibiting Mitochondrial Protein Synthesis?
Author(s) -
Michio Hirano,
Lluís Palenzuela,
Noah M. Hahn,
R.P. Nelson,
Janet N. Arno,
Christian Schobert,
R. A. Bethel,
Ł Ostrowski,
Manjuli R. Sharma,
P. P. Datta,
Rajendra K. Agrawal,
Jennifer E. Schwartz
Publication year - 2005
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1086/430441
Subject(s) - linezolid , lactic acidosis , 23s ribosomal rna , medicine , toxicity , ribosomal rna , mitochondrial toxicity , acidosis , pharmacology , microbiology and biotechnology , biochemistry , rna , biology , bacteria , genetics , ribosome , gene , staphylococcus aureus , vancomycin
Linezolid, an oxazolidinone antibiotic, inhibits bacterial protein synthesis by binding to 23S ribosomal RNA (rRNA). We studied 3 patients who experienced lactic acidosis while receiving linezolid therapy. The toxicity may have been caused by linezolid binding to mitochondrial 16S rRNA. Genetic polymorphisms may have contributed to the toxicity in 2 patients.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom